Skip to main content

Table 2 Participants medication of HF (n = 448)

From: Managing patients with heart failure: contemporary real-world experience

  Total-448
n (%)
Hospital Group-173
n (%)
Clinic Group-275
n (%)
P-Value
Beta-blockers 381 (85) 132 (76.3) 249 (90.5) < 0.001
Hydralazine 33 (7.4) 26 (15) 7 (2.5) < 0.001
Nitrates 139 (31) 85 (49.1) 54 (19.6) < 0.001
Diuretics 347 (77.5) 163 (94.2) 184 (66.9) < 0.001
MRA     < 0.001
 No 316 (70.5) 169 (97.7) 147 (53.5)  
 Aldactone 129 (28.8) 4 (2.3) 125 (45.5)  
 Eplerenone 3 (0.7) 0 3 (1.1)  
ARBs & ACE inhibitors     < 0.001
 No 97 (21.6) 60 (34.7) 37 (13.5)  
 ACE inhibitors 258 (57.6) 77 (44.5) 181 (65.8)  
 ARBs 93 (20.8) 36 (20.8) 57 (20.7)